Magnesium Citrate

Description

Be Health Magnesium Citrate is a dietary supplement formulated to provide magnesium in the form of citrate. This product is presented in a grape-flavored dosage form, designed for ease of consumption. Magnesium citrate is known for its bioavailability and is commonly used to support various physiological functions, including muscle and nerve function, as well as maintaining normal bone structure. The specific formulation and flavoring enhance the palatability of the supplement, making it suitable for individuals seeking to increase their magnesium intake.

Uses and Indications

This drug is indicated for the relief of occasional constipation (irregularity). It generally produces a bowel movement within 1/2 to 6 hours of administration.

Limitations of Use: There are no known teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The medication should be shaken well before use. It is recommended that patients drink a full glass (8 ounces) of liquid with each dose to ensure proper administration.

For adults and children aged 12 years and older, the dosage ranges from 6.5 to 10 fluid ounces, with a maximum limit of 10 fluid ounces within a 24-hour period.

For children aged 6 to under 12 years, the appropriate dosage is between 3 to 7 fluid ounces, not exceeding 7 fluid ounces in a 24-hour period.

For children aged 2 to under 6 years, the dosage should be 2 to 3 fluid ounces within a 24-hour timeframe, with a maximum of 3 fluid ounces allowed in that period.

For children under 2 years of age, it is advised to consult a physician for appropriate dosing recommendations.

The medication may be administered as a single daily dose or divided into multiple doses as deemed necessary.

Contraindications

Use of this product is contraindicated in patients experiencing rectal bleeding or failure to have a bowel movement after use, as these may indicate a serious underlying condition requiring medical evaluation.

Additionally, caution is advised for patients taking other medications; it is recommended to consult a healthcare professional prior to use. This product should be administered at least 2 hours before or after other drugs, as laxatives may alter the efficacy of concurrent medications.

Warnings and Precautions

Patients with a history of kidney disease should exercise caution when using this medication, as it may exacerbate their condition. Additionally, individuals on a magnesium-restricted diet must be aware of the potential for increased magnesium levels, which could lead to serious complications.

Abdominal pain, nausea, or vomiting may occur during treatment. If these symptoms arise, it is advisable to consult a healthcare professional. Furthermore, any sudden change in bowel habits that persists for more than two weeks warrants immediate medical evaluation, as it may indicate an underlying issue. Patients who have been using a laxative for longer than one week should also seek medical advice, as prolonged use can lead to dependency or other gastrointestinal complications.

In the event of an overdose, it is critical to seek emergency medical assistance or contact a Poison Control Center without delay.

Patients should discontinue use and contact their healthcare provider if they experience rectal bleeding or fail to have a bowel movement after administration. These symptoms may signify a serious medical condition that requires prompt attention.

Side Effects

Patients should be aware of several warnings associated with the use of this medication. Individuals with kidney disease or those on a magnesium-restricted diet should exercise caution. Additionally, patients experiencing abdominal pain, nausea, or vomiting should consult a healthcare professional. A sudden change in bowel habits that persists for more than two weeks, or the use of a laxative for longer than one week, also warrants medical attention.

Patients are advised to stop using the medication and seek medical advice if they experience rectal bleeding or failure to have a bowel movement after use, as these symptoms may indicate a serious underlying condition.

Drug Interactions

The use of this product should be carefully timed in relation to other medications. It is recommended that this product be administered at least 2 hours before or after the administration of other drugs to minimize potential interactions.

Particular attention should be given to laxatives, as they may influence the efficacy of concurrent medications. Monitoring for therapeutic effectiveness of other drugs may be warranted when used in conjunction with this product.

Packaging & NDC

Below are the non-prescription pack sizes of Magnesium Citrate (be health magnesium citrate oral solution - grape). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 12 years and older may receive a dosage of 6.5 to 10 fl oz, with a maximum limit of 10 fl oz in a 24-hour period. For children aged 6 to under 12 years, the recommended dosage is 3 to 7 fl oz, not exceeding 7 fl oz in 24 hours. In children aged 2 to under 6 years, the dosage is 2 to 3 fl oz, with a maximum of 3 fl oz in 24 hours. For infants and children under 2 years of age, it is advised to consult a doctor before administration.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients should consult a healthcare professional before using this medication. The safety of this drug during pregnancy has not been established, and potential risks to fetal outcomes are not fully understood. It is essential for women of childbearing potential to discuss their individual circumstances with their healthcare provider to weigh the benefits and risks associated with the use of this medication during pregnancy.

Lactation

Lactating mothers are advised to consult a healthcare professional prior to using this medication. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating mothers.

Renal Impairment

Patients with renal impairment may require careful consideration regarding dosing adjustments and monitoring. In individuals with reduced kidney function, particularly those with kidney disease, it is essential to assess renal clearance to ensure appropriate therapeutic levels are maintained. Additionally, patients on a magnesium-restricted diet should be monitored closely, as renal impairment can affect magnesium levels and overall electrolyte balance. Regular evaluation of renal function is recommended to guide treatment decisions and minimize the risk of adverse effects.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise clinical judgment when considering the use of this medication in patients with liver problems, as the absence of specific guidance necessitates careful evaluation of the patient's overall health status and liver function.

Overdosage

In the context of overdosage, it is important to note that there is no specific information available regarding overdosage in the current sections of the drug insert.

Healthcare professionals are advised to exercise caution and consider standard management protocols for suspected overdosage cases. In the absence of detailed guidance, it is recommended that clinicians monitor the patient closely for any adverse effects and provide supportive care as necessary.

Should symptoms arise, appropriate symptomatic treatment should be initiated based on the clinical presentation. It is essential to consult local poison control centers or relevant toxicology resources for further assistance in managing potential overdosage scenarios.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center in the event of an overdose. It is crucial for patients to understand the importance of stopping the use of this product and consulting a doctor if they experience rectal bleeding or fail to have a bowel movement after use, as these symptoms may indicate a serious underlying condition.

Patients should also be encouraged to consult with their healthcare provider or pharmacist prior to using this product if they are currently taking any other medications. It is important to inform patients that they should take this product at least 2 hours before or after taking other drugs, as laxatives may influence the effectiveness of other medications.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at temperatures ranging from 46° to 86°F (8° to 30°C) to maintain its efficacy and integrity. Proper storage conditions must be adhered to, ensuring that the product is kept within the specified temperature range to prevent degradation.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Magnesium Citrate, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)